Water intake in rats subjected to hypothalamic immunoneutralization of angiotensin II, atrial natriuretic peptide, vasopressin, or oxytocin.
To investigate the influence of various peptides on control of dehydration-induced drinking, water intake elicited by overnight water deprivation was analyzed in groups of male rats after intracerebroventricular (third ventricle, icv) injection of 2 microliters of normal rabbit serum or an equal volume of antiserum directed against angiotensin II (Ab-AII), atrial natriuretic peptide, vasopressin, or oxytocin. There was no difference in water intake after normal rabbit serum and antiserum injections when water was offered immediately after icv injections. Water intake was greatly reduced by Ab-AII when water was offered 1 hr and 3 hr after icv injection. The other antisera were partially effective only when water was offered 3 hr after icv injection. The dipsogenic effect of icv injection of AII in normally hydrated rats was reduced only by icv injection of Ab-AII 3 hr before and not by the other antisera. Ab-AII injected icv had no effect on the drinking that occurred just before and after the onset of darkness and that was associated with eating (prandial drinking). The results indicate that AII is primarily responsible for dehydration-induced drinking, and the other peptides may play a permissive role since their antisera were partially effective, with longer latencies after antiserum injection, which is perhaps the result of gradual diffusion to effective sites within the hypothalamus. In contrast, endogenous AII appears to play little, if any, role in prandial drinking.
Franci
C R
CR
Universidade de Sao Paulo, Faculdade de Medicina, Ribeirao Preto, Brazil.
Kozlowski
G P
GP
McCann
S M
SM
D000804:Angiotensin II / Q000276:immunology / Q000502:physiology*; D000818:Animals; D000937:Antigen-Antibody Reactions; D009320:Atrial Natriuretic Factor / Q000276:immunology / Q000502:physiology*; D003681:Dehydration / Q000503:physiopathology; D004327:Drinking Behavior / Q000502:physiology*; D007031:Hypothalamus / Q000502:physiology*; D008297:Male; D008845:Microinjections; D010121:Oxytocin / Q000276:immunology / Q000502:physiology*; D051381:Rats; D014667:Vasopressins / Q000276:immunology / Q000502:physiology*; D014882:Water-Electrolyte Balance
D014667:Vasopressins; D000804:Angiotensin II; D010121:Oxytocin; D009320:Atrial Natriuretic Factor